Dr. Gary Gilliland
Dr. Gary Gilliland is president and director of Seattle’s Fred Hutchinson Cancer Research Center. He is an expert in cancer genetics and precision medicine who has devoted his life to finding better treatments and cures for diseases.
Resources for more information
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Aug. 10, 2017 in Hutch News
Celebrating faculty and staff achievements
July 20, 2017 in Hutch News
Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care
July 6, 2017 in Hutch News
The cancer center continues to expand its business and tech bench as it seeks to speed the discovery of new cures
June 29, 2017 in Hutch News
Immunotherapy, health disparities, funding cuts among hot topics at annual meeting
April 7, 2017 in Hutch News
At annual meeting of cancer researchers, Biden shared highlights of cancer effort so far ― and doled out encouragement in midst of threatened cuts to science
April 4, 2017 in Hutch News
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
March 30, 2017 in Hutch News
Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland
March 30, 2017 in News Releases
Celebrating faculty and staff achievements
March 23, 2017 in Hutch News
Celebrating faculty and staff achievements
March 3, 2017 in Hutch News
FOR THE MEDIA
Hutch Team
For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.
